Cowen offers innovative alternative investment products ranging from public market hedge to private equity, to royalties.
Over decades, Cowen’s leadership has proven its ability to utilize balance sheet capital to build, grow and foster the investment teams that have brought vital and relevant strategies to our clients.
The founding managing members of the investment management division (Peter Cohen, Thomas Strauss, Jeff Solomon, and the late Morgan Stark) utilized decades of extensive experience derived from prior positions at the most senior levels in global capital markets and investment management to build Cowen’s investment management division.
We have an established network of relationships within the global financial community, as well as a seasoned perspective on the disciplines required to manage successful investment programs. In addition, we have assembled a professional support staff with their own extensive experience within their disciplines.
The founding managing members and senior-level professionals have collectively made significant personal investments in both the investment management division and, alongside Cowen’s clients, in most of the various portfolio strategies.
Cowen Healthcare Investments
Cowen Healthcare Investments was founded to capitalize on the tremendous pace of change and innovation in the healthcare sector. The team has considerable private biopharma investing experience and a disciplined investment history driven by deep diligence of underlying science.
Kevin RaidyManaging Partner, Cowen Healthcare Investments646 562 1288
Cowen Sustainable Investments
Cowen Sustainable Investments (CSI) was founded to provide tailored financing solutions to companies accelerating the world’s transition to an environmentally sustainable economy. The CSI team has deep investment expertise in traditional industries being disrupted by cost reductions in sustainable technologies that are transforming the transportation, energy, agriculture/food, and manufacturing sectors.
The investment themes pursued by CSI include renewables and storage, clean transportation, sustainable food production and industrial efficiency. We focus on companies with proven technologies and strong management teams entering the next stage of their development and requiring financing for corporate growth and deployment of sustainable real assets at scale.
Ramius Advisors LLC (“Ramius”) pursues event driven and merger arbitrage strategies. Ramius employs a differentiated approach to investing in merger arbitrage that is driven by fundamental research and conviction.
The Ramius merger strategy is a focused portfolio of merger arbitrage transactions, seeking capital efficiency while managing risk through downside projections and dynamic trading.
Ethan JohnsonManaging Director, Partner, and Portfolio Manager, Ramius Merger Arbitrage Strategy212 201 4862
599 Lexington Avenue
New York, NY 10022
T 212 201 4870
Starboard Value LP is a New York-based investment adviser with a focused and fundamental approach to investing in publicly-traded US companies. Starboard invests in deeply undervalued companies and actively engages with management teams and boards of directors to identify and execute on opportunities to unlock value for the benefit of all shareholders.
Starboard’s principals have managed investments in this manner since 2002.
Healthcare Royalty Partners
HealthCare Royalty Partners is a multi-billion dollar global healthcare investment firm. Founded in 2006, HealthCare Royalty Partners has raised cumulative capital commitments of $4.8 billion to invest in commercial and near-commercial stage life science assets.
HealthCare Royalty Partners investments primarily consist of royalty purchases and debt or debt-like structures. This asset class offers uncorrelated yield and is typically protected by high barriers to entry.
300 Atlantic Street, Suite 600
Stamford, CT 06901
T 203 487 8300
F 203 487 8330
Triartisan Capital Advisors
TriArtisan Capital Advisors is a private equity investing firm focused on making differentiated investments in public and private companies across a broad range of industries.
Our access to institutional capital enables us to make investments in middle and larger capitalization companies as either a lead sponsor or in partnership with many of the world’s leading private equity firms.
Gerald H. CromackManaging Director and Co-Founder, TriArtisan(212)609 0620
Rohit ManochaManaging Director and Co-Founder, TriArtisan(212) 609 0620
830 3rd Avenue, 4th Floor
New York, NY 10022
T 212 609 0620
For more than two decades, we have demonstrated our ability to identify investment talent and build differentiated products and solutions. We translate that know-how to help investment teams - our partners - build sustainable investment businesses.
Elizabeth Flisser RosmanManaging Director and Head, Investment Management212 845 7948